Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Microplate Designed for High-Resolution Microscopy

By LabMedica International staff writers
Posted on 12 Mar 2013
A new, black 96-well microplate includes an ultra-low well base that enables high-magnification microscopy, inclusive of perimeter wells, even with a minimum working distance. More...


Greiner Bio-One (Frickenhausen, Germany) now expands its microplate portfolio with the introduction of “ScreenStar” at the 2013 Society for Laboratory Automation and Screening (SLAS) conference exhibition in Orlando (FL, USA). The ScreenStar design includes several new features. Manufactured entirely of cycloolefin, an innovative material with glass-like optical properties, it facilitates outstanding image quality of well contents. The microplate has a 190 μm ultraclear film bottom. The key advantage of ScreenStar over other plates for high-resolution microscopy is the extremely short distance between the well bottom and the microplate skirt (internal well to skirt bottom = 0.7 mm; external well to skirt bottom = 0.51 mm), rendering ease of high magnification microscopy at perimeter wells without complex microscopic adjustments. The circular wells allow microscopic work without disruptive shadow using the smallest possible meniscus lens. The perimeter ditch can be filled with water or medium to reduce edge effect due to evaporation, especially for long incubation periods. A proven cell culture-treatment quality ensures reliable, uniform growth.

The black, 96-well, 190 μm clear film bottom, cell culture treated, cycloolefin ScreenStar microplate comes sterile with lid, individually packed. Well bottoms are protected by a film that must be removed prior to use. The identical microscopy plate with a glass bottom will be introduced shortly.

Related Links:
Greiner Bio-One



Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Multi-Chamber Washer-Disinfector
WD 390
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: NeoCircle Study Synopsis (George, A.M., Chen, Y., Gladchuk, S. et al. EMBO Molecular Medicine (2026). DOI: 10.1038/s44321-026-00447-z)

Ultrasensitive MRD Blood Test Detects Early Breast Cancer Recurrence

SAGA Diagnostics (Morrisville, NC, USA), a company specializing in tumor-informed, blood-based cancer detection and precision medicine, announced the publication of a new study evaluating its Pathlight... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.